Search by Drug Name or NDC
NDC 36800-0533-78 Topcare Migraine Relief 250; 250; 65 mg/1; mg/1; mg/1 Details
Topcare Migraine Relief 250; 250; 65 mg/1; mg/1; mg/1
Topcare Migraine Relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Topco Associates LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 36800-0533 |
|---|---|
| Product ID | 36800-533_1af50aea-ee43-46d6-a620-7ff51d2fb353 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Topcare Migraine Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | Topco Associates LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075794 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 36800-0533-78 (36800053378)
| NDC Package Code | 36800-533-78 |
|---|---|
| Billing NDC | 36800053378 |
| Package | 1 BOTTLE in 1 CARTON (36800-533-78) / 100 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2018-07-20 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |